Clinical Trial Update: Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF) [Phase 2]

View source ↗

Summary

This update documents the RESPECT-HF Phase 2 trial evaluating renal denervation in heart failure with preserved ejection fraction, with the current study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Renal denervation

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Heart Failure | Phase 2 | Status: UNKNOWN